Lungs News and Research

RSS

Innovative approaches to develop more effective interventions to reduce obesity

The National Institutes of Health is launching a $37 million program that will use findings from basic research on human behavior to develop more effective interventions to reduce obesity.

13 Dec 2009

Anti-estrogens may reduce the risk of death from lung cancer, according to study results

Anti-estrogens as therapy for breast cancer may also reduce the risk of death from lung cancer, according to study results presented at the CTRC-AACR San Antonio Breast Cancer Symposium, held here Dec. 9-13, 2009.

11 Dec 2009

HTDS comments on its recent stock price activity

Hard to Treat Diseases (HTDS) http://www.htdsmedical.com the company has been asked to comment on recent activity in its stock price. First, we would like our shareholders to be reassured and take comfort in the fact that there is no news that they do not know about. While there are several significant pending transactions they are not ready to be announced yet, however will be in due and appropriate time.

11 Dec 2009

Sage MIP Fund Accounting version 10.2 now available with built-in feedback mechanism

Sage North America today announced version 10.2 of its Sage MIP Fund Accounting nonprofit and government financial management software, featuring a new customer feedback portal allowing customers to quickly submit ideas and feedback to Sage MIP Fund Accounting product executives.

11 Dec 2009

French team develops robotic technology to operate on a beating heart

If you've been waiting for the day to arrive when computers actually start performing surgery, that moment might soon be upon us. A French team has developed a computerized 3D model that allows surgeons to use robotics to operate on a beating heart, according to a report in The International Journal of Robotics Research, published by SAGE.

11 Dec 2009

NIH launches a $37 million program to reduce obesity

The National Institutes of Health is launching a $37 million program that will use findings from basic research on human behavior to develop more effective interventions to reduce obesity.

11 Dec 2009

Initiation of multi-national Phase III study of Stimuvax announced

Merck KGaA, Darmstadt, Germany, today announced the initiation of its multi-national Phase III study of the investigational therapeutic cancer vaccine Stimuvax® (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC).

11 Dec 2009

Michigan goes smoke-free

The Michigan Legislature today delivered a historic victory for health and the public's right to breathe clean air by passing legislation to make almost all workplaces, including all restaurants and bars, smoke-free. Gov. Jennifer Granholm has said she will sign the bill, which will make Michigan the 27th state to pass a strong smoke-free law that includes all restaurants and bars.

10 Dec 2009

Biomoda, Christiana Care Health System partner in study of CyPath lung cancer diagnostic test

Cancer diagnostics company Biomoda, Inc. today announced that The Helen F. Graham Cancer Center associated with Christiana Care Health System, a screening site for the International Early Lung Cancer Program (I-ELCAP), will recruit a cohort of patients diagnosed with lung cancer to participate in the final stage of the Phase II pilot study of the investigational CyPath® assay, an early-stage diagnostic test for lung cancer.

10 Dec 2009

New brain metastases treatment guidelines

New treatment guidelines for patients with brain metastases are now available from the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS).

10 Dec 2009

Merck commences Stimuvax Phase 3 trial in Asian patients with NSCLC

Oncothyreon Inc. today announced that Merck KGaA of Darmstadt, Germany, has initiated a Phase 3 trial of Stimuvax(R) (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC). The trial, named INSPIRE (Stimuvax trial In Asian NSCLC Patients: Stimulating Immune Response), is anticipated to enroll approximately 420 patients in China, Hong Kong, South Korea, Singapore and Taiwan.

10 Dec 2009

Second-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. today announced financial results for the second quarter of fiscal year (FY) 2010 ended October 31, 2009. Total revenue for the second quarter of FY 2010 increased 255% to $6,896,000, compared to $1,941,000 for the comparable prior year quarter.

10 Dec 2009

Event proceeds to benefit Virginia G. Piper Cancer Center at Scottsdale Healthcare

Scottsdale Healthcare Foundation announced today that Daniel Von Hoff, MD will be Honoree at its 34th annual Honor Ball. Dr. Von Hoff, an oncologist and chief scientific officer at Scottsdale Healthcare's Virginia G. Piper Cancer Center, is known worldwide for his groundbreaking cancer research.

10 Dec 2009

Tobacco prevention and cessation programs: States cut funding by more than 15%

The states are collecting record amounts of revenue from the 1998 tobacco settlement and tobacco taxes, but have cut funding for programs to reduce tobacco use by more than 15 percent in the past year, according to a report released today by a coalition of public health organizations.

10 Dec 2009

Patients' urine may provide rapid diagnosis of pneumonia

Doctors may soon be able to quickly and accurately diagnose the cause of pneumonia-like symptoms by examining the chemicals found in a patient's urine, suggests a new study led by UC Davis biochemist Carolyn Slupsky.

10 Dec 2009

Updated NCCN Guidelines include maintenance therapy for patients with metastatic disease

The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) to incorporate a new section about maintenance therapy, a number of new indications for specific therapies for advanced NSCLC, and the recently revised staging system for lung cancer.

10 Dec 2009